Speeches and Writing
Remarks at Mayo Clinic
December 15, 2011
Note: Remarks are as prepared for delivery.
Dr. Noseworthy (President & CEO Mayo Clinic), Regent Simmons, honored guests …
I am thrilled and honored to be a part of this renewed agreement and would like to reiterate and pledge our continued commitment to work together to advance health care through innovation in research and education.
I was immensely impressed by all that I saw during our tour of the Genomics center. But I am most excited about something you just mentioned.
It even makes me giddy with hope.
Given the power of our two great medical institutions, our mutual commitment to the study of genomics, and the Clinic's unique work on aging - I have great hope that you and I just might be here in 100 years to measure how well we've done!
Seriously, as Dr. Noseworthy said, our connections are longstanding and special, and it is with great pleasure that I am participating in extending our agreement and deepening our partnership, which exists on so many levels.
I toured BIC-B when I was in Rochester earlier this year. Talk about a partnership! UMR, U of M Twin Cities, IBM, Mayo Clinic, Hormel Institute. That is a virtual family of progress and science.
As for the two of us, Mayo Clinic and the University of Minnesota are both premier global research institutions.
- We each create knowledge.
- We each push science in new directions.
- We each drive innovation.
In the end, together, we make history.
That history is forged by leveraging the profound power and promise in the collaborative value of our two great institutions as we work together for the people of Minnesota, the health of the nation, and discoveries that will change the world.
We are a dream team that transforms this state into a magnet for talent, that - with IBM - continually makes Rochester one of the most livable cities in the nation, and that makes the Twin Cities the largest cultural center from Chicago to Seattle, and home to 20 Fortune 500 companies.
Just last week, we told our Board of Regents about a new model to translate the discoveries of our scientists into useful and powerful intellectual property.
It's not merely a question of who owns the IP.
We are most concerned about enhancing the value of the IP.
It is a research-to-marketplace model that attempts to eliminate hurdles and prolonged negotiations.
It is a model that honors and encourages collaboration.
Our partnership with the Clinic blazed that trail of collaboration.
And our joint Decade of Discovery, with the initial goal of conquering diabetes, is the sort of ambition that will drive us to life-changing science, to job creation and to cures.
Thank you, Dr. Noseworthy, thank you Mayo Clinic.
We are proud to be your colleagues. We are honored to be your partners. See you in 100 years!